Helen Albert
Editor-in-chief at Labiotech. Keen photographer, book lover, foodie and travel enthusiast. Passionate about interesting bioscience and its many applications. Always open to ideas for new content and reader feedback.
Riding the Wave of Cambridge Entrepreneurship
Update: BioNTech Confirms Pfizer Coronavirus Vaccine Collaboration
Why Women’s Health Can Be a Good Investment
Alnylam Gets Second RNAi Drug Approval from EMA
Evonetix Raises €27M Series B to Progress DNA Synthesis Technology
Bicycle Therapeutics Partners Genentech in Deal Worth €1.6B
Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial
OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology
Why European Biotechs Should Look to China for Investment
Why a Big Pharma Background Can Give Biotech Leaders an Edge
